Kenneth Blum, David Baron, Thomas McLaughlin, Panayotis K Thanos, Catherine Dennen, Mauro Ceccanti, Eric R Braverman, Alireza Sharafshah, Kai-Uwe Lewandrowski, John Giordano, Rajendra D Badgaiyan
{"title":"RDS 防沉迷模型研究摘要文件：附加说明的参考书目。","authors":"Kenneth Blum, David Baron, Thomas McLaughlin, Panayotis K Thanos, Catherine Dennen, Mauro Ceccanti, Eric R Braverman, Alireza Sharafshah, Kai-Uwe Lewandrowski, John Giordano, Rajendra D Badgaiyan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Annotated bibliography of genetic addiction risk severity (GARS) publications, pro-dopamine regulation in nutraceuticals (KB220 nutraceutical variants), and policy documents. Further research is required to encourage the field to consider \"Reward Deficiency Syndrome (RDS) Anti-addiction Modeling\" which involves early risk identification by means of genetic assessment similar to GARS, followed by induction of dopamine homeostasis by means of genetically guided pro-dopamine regulation similar to KB220. These results suggest that genetically based treatments may be a missing piece in the treatment of substance use disorder (SUD).</p>","PeriodicalId":73582,"journal":{"name":"Journal of addiction psychiatry","volume":"8 1","pages":"1-33"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100022/pdf/","citationCount":"0","resultStr":"{\"title\":\"Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.\",\"authors\":\"Kenneth Blum, David Baron, Thomas McLaughlin, Panayotis K Thanos, Catherine Dennen, Mauro Ceccanti, Eric R Braverman, Alireza Sharafshah, Kai-Uwe Lewandrowski, John Giordano, Rajendra D Badgaiyan\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Annotated bibliography of genetic addiction risk severity (GARS) publications, pro-dopamine regulation in nutraceuticals (KB220 nutraceutical variants), and policy documents. Further research is required to encourage the field to consider \\\"Reward Deficiency Syndrome (RDS) Anti-addiction Modeling\\\" which involves early risk identification by means of genetic assessment similar to GARS, followed by induction of dopamine homeostasis by means of genetically guided pro-dopamine regulation similar to KB220. These results suggest that genetically based treatments may be a missing piece in the treatment of substance use disorder (SUD).</p>\",\"PeriodicalId\":73582,\"journal\":{\"name\":\"Journal of addiction psychiatry\",\"volume\":\"8 1\",\"pages\":\"1-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100022/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of addiction psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of addiction psychiatry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.
Annotated bibliography of genetic addiction risk severity (GARS) publications, pro-dopamine regulation in nutraceuticals (KB220 nutraceutical variants), and policy documents. Further research is required to encourage the field to consider "Reward Deficiency Syndrome (RDS) Anti-addiction Modeling" which involves early risk identification by means of genetic assessment similar to GARS, followed by induction of dopamine homeostasis by means of genetically guided pro-dopamine regulation similar to KB220. These results suggest that genetically based treatments may be a missing piece in the treatment of substance use disorder (SUD).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
